Company: PharmaEssentia Corporation
Bloomberg ticker: 6446 TT
Market cap: US$7,259m
Background: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.
World Class Benchmarking of PharmaEssentia Corp
(Click on image to enlarge)
- Profitable Growth rank of 6 was up compared to the prior period’s 9th rank
- This is below average performance compared to 350 medium Health Care companies worldwide
- Profitability rank of 6 was worse than its Growth rank of 2
- Profitability rank of 6 was up compared to the prior period’s 9th rank
- This is below average performance compared to peers
- Growth rank of 2 was the same compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
More By This Author:
Asian Stock: Jiangsu Hengrui PharmaceuticalsAsian Stock: Zhejiang China Commodities City Group
Asian Stock: President Chain Store Corp
Comments
Log in or sign up to join the conversation.